Primmune Therapeutics

Recent Finacing

Series B ext

Recent Raise

$8.6M

Primmune Therapeutics is a Carlsbad-based clinical-stage biotech developing orally administered TLR7 agonist immunotherapies for cancer and other immune-responsive diseases.

California, United States

1-10

Private

primmunerx.com

Highlights

Focus Areas

Biotechnology

Health Care

Recent Investors

Financials

$55.4M

Total Raised

5

Funding rounds

8

Investors

Team

Upgrade to view the team

See the team members at Primmune Therapeutics.